Facial volume changes during rapid weight loss, sometimes called Ozempic face, are a separate concern that some patients ask about
Towards understanding brain-gut-microbiome connections in Alzheimers disease
After 72 weeks of treatment: 5 mg dose: 15.0% mean body weight reduction 10 mg dose: 19.5% mean body weight reduction 15 mg dose: 20.9% mean body weight reduction Placebo: 3.1% mean body weight reduction Among participants receiving 15 mg, approximately 57% achieved at least 20% weight loss
The Obesity Medicine Association, the largest organization of clinicians dedicated to preventing, treating, and reversing the disease of obesity, co-authored the 2025 joint advisory on Nutritional Priorities to Support GLP-1 Therapy, identifying adequate protein intake, lean mass preservation, and resistance training as the three most critical nutritional priorities for patients receiving GLP-1 receptor agonists for obesity care
Stacking Strategy: CJC-1295 + Ipamorelin Together Stacking is done to combine the baseline elevation from a GHRH analogue with pulsatile GH bursts from a secretagogue, achieving synergy that often leads to greater GH response 10 than either alone